Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,364.00p on 15-07-2026 at 06:25:02
Change 0.00p 0%
Buy 12,800.00p
Sell 12,100.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 11.00 at 12,438.75785p
Day's Volume: 16
Last Close: 12,364.00p
Open: 0.00p
ISIN: GB0009895292
Day's Range 0.00p - 0.00p
52wk Range: 10,180.00p - 15,730.00p
Market Capitalisation: £191.75b
VWAP: 12,407.0901p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 11 12,438.75785p SI Trade
Currency Conversion
 07:25:02 - 15-Jul-26
Unknown* 1 12,287.27499p SI Trade
Currency Conversion
 06:48:25 - 15-Jul-26
Unknown* 4 12,349.95755p SI Trade
Currency Conversion
 06:00:22 - 15-Jul-26
Unknown* 0 12,349.95755p SI Trade
Currency Conversion
 05:05:10 - 15-Jul-26
Unknown* 0 12,446.96628p SI Trade
Currency Conversion
 00:25:43 - 15-Jul-26
Unknown* 0 12,446.96628p SI Trade
Currency Conversion
 23:27:14 - 14-Jul-26
Unknown* 0 12,434.28052p SI Trade
Currency Conversion
 23:03:56 - 14-Jul-26
Unknown* 0 12,356.67354p SI Trade
Currency Conversion
 21:40:50 - 14-Jul-26
Unknown* 0 12,446.96628p SI Trade
Currency Conversion
 21:31:09 - 14-Jul-26
Unknown* 41 12,293.99098p Currency Conversion
OTC Trade
 21:30:50 - 14-Jul-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Jul 2026 (Tue) 12,580.00 12,590.00 12,328.00 12,364.00 3,312,723
13th Jul 2026 (Mon) 12,722.00 12,810.00 12,546.00 12,610.00 2,741,091
10th Jul 2026 (Fri) 13,322.00 13,412.00 12,784.00 12,834.00 3,354,280
9th Jul 2026 (Thu) 13,204.00 13,354.00 12,738.00 13,354.00 7,622,870
8th Jul 2026 (Wed) 14,312.00 14,320.00 14,086.00 14,240.00 1,479,840
7th Jul 2026 (Tue) 14,172.00 14,478.00 14,110.00 14,364.00 1,527,913
6th Jul 2026 (Mon) 14,500.00 14,526.00 13,954.00 14,100.00 2,007,708
3rd Jul 2026 (Fri) 14,538.00 14,562.00 14,346.00 14,456.00 652,974
2nd Jul 2026 (Thu) 13,916.00 14,686.00 13,894.00 14,538.00 2,810,151
1st Jul 2026 (Wed) 14,138.00 14,230.00 13,840.00 13,854.00 1,804,092
30th Jun 2026 (Tue) 14,356.00 14,536.00 14,054.00 14,100.00 2,512,929
29th Jun 2026 (Mon) 14,364.00 14,386.00 14,200.00 14,298.00 1,883,313
26th Jun 2026 (Fri) 14,038.00 14,326.00 13,900.00 14,318.00 3,945,847
25th Jun 2026 (Thu) 13,862.00 14,134.00 13,786.00 14,062.00 1,790,523
24th Jun 2026 (Wed) 13,588.00 14,018.00 13,584.00 13,910.00 2,775,862
23rd Jun 2026 (Tue) 13,388.00 13,706.00 13,342.00 13,590.00 1,872,524
22nd Jun 2026 (Mon) 13,240.00 13,340.00 13,198.00 13,290.00 1,820,566
19th Jun 2026 (Fri) 13,284.00 13,396.00 13,156.00 13,234.00 4,454,518
18th Jun 2026 (Thu) 13,482.00 13,506.00 13,116.00 13,154.00 1,591,007
17th Jun 2026 (Wed) 13,332.00 13,472.00 13,272.00 13,472.00 1,420,398
16th Jun 2026 (Tue) 13,248.00 13,320.00 13,172.00 13,284.00 4,260,476
15th Jun 2026 (Mon) 13,462.00 13,530.00 13,172.00 13,200.00 1,817,432
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
14th Jul 2026 7:00 am RNS AstraZeneca licenses novel EGFR inhibitor
9th Jul 2026 7:00 am RNS Update on CARDIO-TTRansform Phase III trial
1st Jul 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Jul 2026 3:00 pm RNS Total Voting Rights
29th Jun 2026 7:30 am RNS Enhertu approved in EU for HER2+ solid tumours
29th Jun 2026 7:00 am RNS Datroway recommended for approval in EU for TNBC
15th Jun 2026 7:00 am RNS Truqap approved in US for prostate cancer
1st Jun 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Jun 2026 3:00 pm RNS Total Voting Rights
29th May 2026 7:00 am RNS Imfinzi approved in US for early bladder cancer
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca buys worldwide rights to cancer drug for USD1.5 billion

14th Jul 2026 08:34

(Alliance News) - AstraZeneca PLC on Tuesday said it has entered into a deal to license a lung cancer therapy, in a deal worth up to USD1.5 billion. Read More

LONDON BRIEFING: BP production falls; Astra lands USD1.5 billion deal

14th Jul 2026 07:53

(Alliance News) - BP flags lower second-quarter production but expects stronger oil price realisations, while AstraZeneca agrees a lung cancer licensing deal with Dizal Pharmaceutical worth up to USD1.5 billion. Read More

LONDON BROKER RATINGS: HSBC cuts Astra; Stifel raises Computacenter

13th Jul 2026 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

13th Jul 2026 07:59

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger traffic edged higher despite a June decline caused by weaker Middle East travel. Read More

LONDON MARKET CLOSE: Vodafone lifts FTSE 100 as easyJet backs new bid

10th Jul 2026 17:05

(Alliance News) - The FTSE 100 closed higher on Friday in calmer trading, boosted by double-digit gains from telecommunications firm Vodafone. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,529.39
Change0.00

Login to your account

Forgot Password?

Not Registered